<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table II</label>
 <caption>
  <p>Recent antiviral screening data for Tilorone generated under the NIAID-DMID NCEA antiviral 
   <italic>in vitro</italic> screening services except where noted
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>
     <bold>Virus</bold>
    </th>
    <th>
     <bold>Strain</bold>
    </th>
    <th>
     <bold>Genus</bold>
    </th>
    <th>
     <bold>Type</bold>
    </th>
    <th>
     <bold>Cell line</bold>
    </th>
    <th>
     <bold>EC</bold>
     <sub>
      <bold>50</bold>
     </sub>
     <bold>(μM)</bold>
    </th>
    <th>
     <bold>CC</bold>
     <sub>
      <bold>50</bold>
     </sub>
     <bold>(μM)</bold>
    </th>
    <th>
     <bold>Reference</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>EBOV</td>
    <td>Zaire</td>
    <td>Filovirus</td>
    <td>-ssRNA</td>
    <td>HeLa</td>
    <td>0.23</td>
    <td>6.2</td>
    <td>(
     <xref ref-type="bibr" rid="CR31">31</xref>)
    </td>
   </tr>
   <tr>
    <td>EBOV</td>
    <td>Zaire</td>
    <td>Filovirus</td>
    <td>- ssRNA</td>
    <td>Vero 76</td>
    <td>&gt;11*</td>
    <td>11</td>
    <td>(
     <xref ref-type="bibr" rid="CR32">32</xref>)
    </td>
   </tr>
   <tr>
    <td>MARV</td>
    <td>Musoke</td>
    <td>Filovirus</td>
    <td>- ssRNA</td>
    <td>HeLa</td>
    <td>1.9</td>
    <td>–</td>
    <td>(
     <xref ref-type="bibr" rid="CR33">33</xref>)
    </td>
   </tr>
   <tr>
    <td>Influenza A virus H1N1</td>
    <td>California/07/20/09</td>
    <td>Influenzavirus</td>
    <td>- ssRNA</td>
    <td>MDCK</td>
    <td>&gt;19</td>
    <td>19</td>
    <td/>
   </tr>
   <tr>
    <td>Tacaribe virus</td>
    <td>TRVL 11573</td>
    <td>Arenavirus (new world)</td>
    <td>−/+ ssRNA</td>
    <td>Vero 76</td>
    <td>29*</td>
    <td>32</td>
    <td/>
   </tr>
   <tr>
    <td>CHIKV</td>
    <td>S27 (VR-67)</td>
    <td>Alphavirus</td>
    <td>+ ssRNA</td>
    <td>Vero 76</td>
    <td>4.2*</td>
    <td>32</td>
    <td>(
     <xref ref-type="bibr" rid="CR34">34</xref>)
    </td>
   </tr>
   <tr>
    <td>MERS-CoV</td>
    <td>EMC</td>
    <td>Betacoronavirus</td>
    <td>+ ssRNA</td>
    <td>Vero 76</td>
    <td>3.7*</td>
    <td>36</td>
    <td>(
     <xref ref-type="bibr" rid="CR34">34</xref>)
    </td>
   </tr>
   <tr>
    <td>Poliovirus 3</td>
    <td>WM-3</td>
    <td>Enterovirus</td>
    <td>+ ssRNA</td>
    <td>Vero 76</td>
    <td>&gt;25*</td>
    <td>25</td>
    <td/>
   </tr>
   <tr>
    <td>VEEV</td>
    <td>TC-83</td>
    <td>Alphavirus</td>
    <td>+ ssRNA</td>
    <td>Vero 76</td>
    <td>18*</td>
    <td>32</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>*
   <italic>In vitro</italic> antiviral data in Vero 76 cells may underestimate antiviral activity due to lacking IFN pathways
  </p>
 </table-wrap-foot>
</table-wrap>
